We are proud to share that Dr. Carl F. Nathan, R.A. Rees Pritchett Professor of Microbiology at Weill Cornell Medicine, has been awarded the David and Beatrix Hamburg Award for Advances in Biomedical Research and Clinical Medicine by the National Academy of Medicine.
This prestigious award recognizes biomedical scientists whose discoveries have significantly advanced human health and reduced disease burden. Dr. Nathan is honored for his decades of pioneering work elucidating innate immunity, host–pathogen interactions, and mechanisms by which the immune system combats infectious diseases, including tuberculosis.
Among his many contributions, Dr. Nathan uncovered how lymphocytes release macrophage-activating factor, later shown to be interferon-γ, a key signal enabling macrophages to kill bacteria and tumor cells. He also helped discover that Mycobacterium tuberculosis (Mtb) contains a proteasome, leading to the investigation of pathogen-selective proteasome inhibitors for malaria, Leishmania and a parasitic disease in Africa called “sleeping sickness.”
He will continue to inspire and support our NYC TRAC community with his deep insights on immunology, host–pathogen interactions, and translational science. Please find the full details on the website of Weill Cornell Medicine.